These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7833674)

  • 41. Molecular basis of resistance to thyroid hormone.
    Yen PM
    Trends Endocrinol Metab; 2003 Sep; 14(7):327-33. PubMed ID: 12946875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
    Zavacki AM; Harney JW; Brent GA; Larsen PR
    Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.
    Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotype differences of resistance to thyroid hormone in two unrelated families with an identical mutation in the thyroid hormone receptor beta gene (R320C).
    Weiss RE; Tunca H; Knapple WL; Faas FH; Refetoff S
    Thyroid; 1997 Feb; 7(1):35-8. PubMed ID: 9086567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
    Kitajima K; Nagaya T; Jameson JL
    Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
    Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
    Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Point mutation of T3 receptor-beta gene and syndrome of inappropriate secretion of TSH].
    Okamura K; Fujishima M
    Nihon Rinsho; 1994 Apr; 52(4):935-9. PubMed ID: 8196183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three Japanese patients from two families with generalized resistance to thyroid hormone with mutations in exon 9 of the thyroid hormone receptor beta gene.
    Taniyama M; Ban Y; Momotani N; Makino F; Ito K; Ban Y
    Intern Med; 2001 Aug; 40(8):756-8. PubMed ID: 11518118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma.
    Safer JD; Colan SD; Fraser LM; Wondisford FE
    Thyroid; 2001 Mar; 11(3):281-91. PubMed ID: 11327621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retarded bone growth in thyroid hormone resistance. A clinical study of a large family with a novel thyroid hormone receptor mutation.
    Kvistad PH; Løvås K; Boman H; Myking OL
    Eur J Endocrinol; 2004 Apr; 150(4):425-30. PubMed ID: 15080770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pathogenesis of disorder due to thyroid hormone receptor mutation].
    Nagaya T; Seo H
    Rinsho Byori; 1998 Oct; 46(10):1017-22. PubMed ID: 9816913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T426I a new mutation in the thyroid hormone receptor beta gene in a sporadic patient with resistance to thyroid hormone and dysmorphism. Mutations in brief no. 192. Online.
    Menzaghi C; Di Paola R; Corrias A; Einaudi S; Trischitta V; De Sanctis C; De Filippis V
    Hum Mutat; 1998; 12(4):289. PubMed ID: 10660344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Syndromes of thyroid hormone resistance.
    Beck-Peccoz P; Mannavola D; Persani L
    Ann Endocrinol (Paris); 2005 Jun; 66(3):264-9. PubMed ID: 15988389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid hormone resistance: Mechanisms and therapeutic development.
    Yao B; Yang C; Pan C; Li Y
    Mol Cell Endocrinol; 2022 Aug; 553():111679. PubMed ID: 35738449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of patients with late manifestation of resistance thyroid hormone syndrome: a single-center experience.
    Han R; Ye L; Jiang X; Zhou X; Billon C; Guan W; Gauthier K; Fang W; Wang W; Samarut J; Ning G
    Endocrine; 2015 Dec; 50(3):689-97. PubMed ID: 26041374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extreme thyroid hormone resistance in a patient with a novel truncated TR mutant.
    Phillips SA; Rotman-Pikielny P; Lazar J; Ando S; Hauser P; Skarulis MC; Brucker-Davis F; Yen PM
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5142-7. PubMed ID: 11701667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mutant thyroid hormone receptor beta 1 identified in a patient with resistance to thyroid hormone inhibits the activities of not only the wild-type TRs, but also other nuclear receptors.
    Miyoshi Y; Nakao K
    Biochem Biophys Res Commun; 1997 Sep; 238(1):39-43. PubMed ID: 9299447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe form of thyroid hormone resistance in a patient with homozygous/hemizygous mutation of T3 receptor gene.
    Frank-Raue K; Lorenz A; Haag C; Höppner W; Boll HU; Knorr D; Hentze S; Raue F
    Eur J Endocrinol; 2004 Jun; 150(6):819-23. PubMed ID: 15191352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mosaicism of a thyroid hormone receptor-beta gene mutation in resistance to thyroid hormone.
    Mamanasiri S; Yesil S; Dumitrescu AM; Liao XH; Demir T; Weiss RE; Refetoff S
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3471-7. PubMed ID: 16804041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
    Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE
    J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.